Literature DB >> 21920244

Latitude and psoriasis prevalence.

Christine C Jacobson1, Sandeep Kumar2, Alexa B Kimball3.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21920244     DOI: 10.1016/j.jaad.2009.05.047

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  8 in total

Review 1.  Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis.

Authors:  Angel Yun-Kuan Thye; Yi-Rou Bah; Jodi Woan-Fei Law; Loh Teng-Hern Tan; Ya-Wen He; Sunny-Hei Wong; Sivakumar Thurairajasingam; Kok-Gan Chan; Learn-Han Lee; Vengadesh Letchumanan
Journal:  Biomedicines       Date:  2022-04-30

2.  Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy.

Authors:  Paolo Gisondi; Camilla Dalle Vedove; Giampiero Girolomoni
Journal:  Dermatol Ther (Heidelb)       Date:  2014-01-23

3.  Activated Circulating T Follicular Helper Cells Are Associated with Disease Severity in Patients with Psoriasis.

Authors:  Ying Wang; Lili Wang; Haoyu Yang; Weichang Yuan; Jingyi Ren; Yanping Bai
Journal:  J Immunol Res       Date:  2016-09-28       Impact factor: 4.818

Review 4.  Update on biologic safety for patients with psoriasis during pregnancy.

Authors:  Martina L Porter; Stephen J Lockwood; Alexa B Kimball
Journal:  Int J Womens Dermatol       Date:  2017-02-04

5.  Regional variations and prevalence of psoriasis in Germany from 2010 to 2017: a cross-sectional, spatio-epidemiological study on ambulatory claims data.

Authors:  Valerie Andrees; Sandra Wolf; Matthias Augustin; Nicole Mohr; Jobst Augustin
Journal:  BMJ Open       Date:  2021-11-16       Impact factor: 2.692

6.  Psoriasis comorbidities in Germany: A population-based study on spatiotemporal variations.

Authors:  Jobst Augustin; Sandra Wolf; Brigitte Stephan; Matthias Augustin; Valerie Andrees
Journal:  PLoS One       Date:  2022-03-22       Impact factor: 3.240

Review 7.  Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy.

Authors:  Baohua Zhu; Mingyi Jing; Qianying Yu; Xiaopei Ge; Fan Yuan; Lanhui Shi
Journal:  Postepy Dermatol Alergol       Date:  2021-08-16       Impact factor: 1.664

8.  Tumor Necrosis Factor-α 308 G/A polymorphism and psoriasis risk: A pooled analysis in different populations.

Authors:  Cuicui Shen; Haiyan Wang; Qunxian Song; Bing Zhang; Xuewei Liu; Jianwei Li
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.